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Transmissible spongiform encephalopathies (TSE) are characterized by the misfolding of
the host encoded prion protein (PrPC) into a pathogenic isoform (PrPSc) which leads to the
accumulation of β-sheet-rich ﬁbrils and subsequent loss of neurons and synaptic functions.
Although many compounds have been identiﬁed which inhibit accumulation or dissolve
ﬁbrils and aggregates in vitro there is no therapeutic treatment to stop these progressive
neurodegenerative diseases. Here we describe the effects of the traditional medicinal herb
Scutellaria lateriﬂora (S. lateriﬂora) and its natural compounds, the ﬂavonoids baicalein and
baicalin, on the development of prion disease using in vitro and in vivo models. S. lateriﬂora
extract as well as both constituents reduced the PrPres accumulation in scrapie-infected
cell cultures and cell-free conversion assays and lead to the destabilization of pre-existing
PrPSc ﬁbrils. Moreover, tea prepared from S. lateriﬂora, prolonged signiﬁcantly the incuba-
tion time of scrapie-infected mice upon oral treatment. Therefore S. lateriﬂora extracts as
well as the individual compounds can be considered as promising candidates for the devel-
opment of new therapeutic drugs againstTSEs and other neurodegenerative diseases like
Alzheimer’s and Parkinson’s disease.
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INTRODUCTION
Transmissible spongiform encephalopathies (TSEs) are neurode-
generative diseases which are characterized by the accumulation
and deposition of a pathogenic isoform (PrPSc) of the host
encoded cellular prion protein (PrPC) designated PrPSc. Both
isoforms share the same amino acid sequence but differ in con-
formation, resistance to proteinase K (PK), and pathogenicity.
PrPSc tends to oligomerize by a seeded polymerization mecha-
nism followed by the formation of multimers and eventually of
ﬁbril structures. This aggregation can be reproduced in an anal-
ogous manner in vitro, using cell-based as well as cell-free assays.
The evolved PrPSc like isoforms – termed PrPres – harbor simi-
lar biochemical characteristics like resistance to Proteinase K and
detection by same antibodies.
Accumulation of PrPSc in the central nervous system (CNS)
is accompanied by neurological dysfunctions, neuronal vacuola-
tion, and astrocytic gliosis. Although the exact disease causing
mechanism is unknown to date, there is evidence for a general
neurotoxicity of these aggregates, which deteriorate synaptic func-
tion and induce oxidative stress and membrane disruption (Soto
and Estrada, 2008). Prion diseases belong to the group of protein
misfolding diseases like Alzheimer’s (AD), Parkinson’s (PD), and
Huntington’s disease (HD), which are generally characterized by
an incorrect folding process of a host encoded protein with a con-
formation different from its native structure. The misfolding is
followed by a self-aggregation and polymerization of the protein
according to a“seeding-nucleation”process (Jarrett and Lansbury,
1993).
As PrPSc formation and aggregation is the central event in
prion diseases, the inhibition of oligomer formation and ﬁbril
extension as well as the enhancement of ﬁbril degradation are
major targets for the development of therapeutic strategies against
TSEs. Several substances have been identiﬁed which inhibit PrPres
formation and accumulation in vitro and prolonged survival in
scrapie-infected animals: Congo red (Caughey and Race, 1992),
branched polyamines (Supattapone et al., 2001), porphyrins and
phthalocyanines (Priola et al., 2000; Caughey et al., 2007), heparan
sulfate mimetics (Adjou et al., 2003), amphotericin (Mange et al.,
2000), curcumine (Caughey et al., 2003; Yang et al., 2009), and
tetracyclines (De Luigi et al., 2008). However, for various reasons
none of these compounds has been included in prevention and
treatment regimes for humans yet. Most recently two new sub-
stance classes, benzothiazoles (Geissen et al., 2011) and diphenyl-
pyrazoles (Leidel et al., 2011), were identiﬁed by high-throughput
screening approaches that inhibit PrPres accumulation in cell cul-
ture models and prolong incubation times in scrapie-infected
mice.
Other therapeutic strategies rely on passive immunization
(White et al., 2003), RNA interference (Pfeifer et al., 2006),
RNA aptamers (Proske et al., 2002), copper chelating antibiotics
(Murakami-Kubo et al., 2004), or on the induction of autophagy
by Lithium (Heiseke et al., 2009).
Recent studies on AD suggest that phenolic compounds like
green tea epigallocatechin gallate (Rezai-Zadeh et al., 2005), herb
extracts like grape seed polyphenolic extract (Wang et al., 2009; Liu
et al., 2011), or medicinal herbs like Paeonia suffruticosa (Fujiwara
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et al., 2009) can be used for the treatment of neurodegenerative
diseases.
The here presented study shows that the American skullcap
Scutellaria lateriﬂora, a traditional medical herb in North Amer-
ica, exhibits strong anti-prion activity. Extracts of this plant have
been traditionally used as sedative and for the treatment of insom-
nia, anxiety, or neuralgia (Foster, 1996). Moreover, we can show
here that the crude aqueous extract inhibits prion propagation
and dissolves prion aggregates in vitro. Continuous oral adminis-
tration of S. lateriﬂora tea (water extract) signiﬁcantly prolonged
incubation times in scrapie-infected mice. Notably, the natural
constituents, the ﬂavonoids baicalein and baicalin-hydrate, exhibit
the same inhibitory effects on prion propagation and dissolve
existing ﬁbrils.
MATERIALS AND METHODS
FLAVONOIDS AND TEA OF SCUTELLARIA LATERIFLORA
Baicalein and baicalein-hydrate were purchased from Sigma-
Aldrich and solubilized in DMSO. The dried herb S. lateriﬂora
was purchased from Goldener Zweig (Buchholz, Germany). Water
extracts (tea) were prepared by mixing 30 g of sliced dry herbs in
1.0 l boiling water for 30min. After cooling the tea was adminis-
tered directly to mice. For in vitro experiments tea was lyophilized
to yield dried extracts. In cell-based assays the dried material was
resuspended in H2O, concentrated by a factor of 10 (termed tea
concentrate) and added to the cell culture medium. In cell-free
conversion assay the dried extract was directly resuspended in the
conversion buffer in a ﬁnal volume of 20 μl.
PROPAGATION OF SCRAPIE STRAINS
C57Bl/6 mice were inoculated with cloned mouse scrapie strains
RML intracerebrally (i.c.; 30 μl of 1% mouse brain homogenate)
or intraperitoneally (i.p.; 50 μl of 1% brain homogenate). The
health status of the mice was inspected daily, and their body
weights were recorded weekly. After the onset of TSE-associated
clinical symptoms (and weight loss, abnormal tail tonus, hind
limbparalysis), the animalswere euthanized. The incubation times
were calculated as the time between inoculation and death. The
brains were removed and kept as following: one half of each brain
was stored at −20˚C, and the other half was ﬁxed in 4% neutral
buffered formalin.
Pathogenic isoform for PrP conversion reactions was puriﬁed
from brains of C57/Bl6 mice i.c. inoculated with mouse scrapie
strain Me7. Brains were taken at the beginning of clinical symp-
toms in the animals and stored at −20˚C. PrPSc was puriﬁed
according to Eiden et al. (2006).
HEMATOXYLIN AND EOSIN STAINING AND IMMUNOHISTOCHEMISTRY
Before embedding in parafﬁn the formalin ﬁxed brain was cut
at ﬁve different levels to reveal caudal medulla, rostral medulla,
midbrain, thalamic, and frontal slices. Lesion proﬁle scoring was
carried out on Hematoxylin and Eosin (H&E) stained sections
according to standard methodology (Fraser and Dickinson, 1968).
For immunohistochemistry samples were processed (with minor
modiﬁcations) as described previously (Hardt et al., 2000). Three
micrometers section were de-parafﬁnized and rehydrated. Pre-
treatment included an incubation step with 98% formic acid
(15min) and blocking of the endogenous peroxidase activity with
3% H2O2/methanol (30min) followed by autoclaving in citrate
buffer (pH 6.0, 20min). The monoclonal antibody SAF 84 was
applied at a dilution of 1:2000 for 2 h at room temperature and
detected by avidin–biotin–horseradish peroxidase (Vector Elite).
Color reactions were ﬁnally developed using diaminobenzidine
(DAB) substrate.
PROTEINASE K DIGESTION AND SODIUM PHOSPHOTUNGSTIC ACID
PRECIPITATION
Mouse brain samples 10% (w/v) were prepared in lysis buffer
(0.42mM sucrose solution containing 0.5% deoxycholic acid
sodium salt (DOC) and 0.5% Non-idet P40) and incubated with
PK (50μg/ml, ﬁnal concentration) for 60min at 55˚C. Reactions
were stopped with pefabloc (Roche) followed by incubation with
0.3%(w/v) phosphotungstic acidprecipitation (PTA) and selective
precipitation of PrPSc according to Gretzschel et al. (2005).
PRP CONVERSION REACTION
Cell-free conversion studies were performed as described before
(Eiden et al., 2006; Kupfer et al., 2007). For the conversion reac-
tion 400 ng of recombinant ovine PrPC, expressed in E. coli, was
incubatedwith 200–400 ng of puriﬁed PrPSc in a conversion buffer
[50mM citrate buffer (pH 6.0), 200mM KCl, 5mM MgCl2, and
1.25% sarkosyl; Horiuchi et al., 2000]. Standard conversion reac-
tions were carried out for 3 days at 37˚C. Afterward, samples were
incubated with PK (ﬁnal concentration of 30μg/ml) for 1 h at
37˚C. PK was diluted in TN-buffer (0.15M NaCl, 0.05M Tris/HCl
pH 7.4). The reaction was stopped with PMSF (phenyl methansul-
fonyl ﬂuoride; 10mM). Twenty micrograms of a carrier protein
(thyroglobulin) was added and the samples were incubated with
a fourfold volume of methanol at –20˚C to precipitate the pro-
teins. After centrifugation at 12000 g for 15min, the proteins were
pelleted and resolubilized by heating to 95˚C for 5min in SDS-
PAGE loading buffer [1% (w/v) SDS, 25mM Tris/HCl pH 7.4,
0.5% mercaptoethanol, and 0.001% bromophenol blue].
Samples were separated on SDS-polyacrylamide gels contain-
ing 16% (w/v) acrylamide/bisacrylamide, 0.375M Tris/HCl (pH
8.8), 0.5% (w/v) SDS (sodium dodecyl sulfate), 0.06% (w/v)
APS (ammonium peroxydisulfate), and 0.06% (v/v) TEMED
(N,N,N ′,N ′-tetramethylethylenediamine) with a 4% stacking gel
[4% (w/v) acrylamide/bisacrylamide, 0.12M Tris/HCl (pH 6.8),
0.5% (w/v) SDS, 0.2% APS, 0.2% (v/v) TEMED].
For immunoblotting proteins were transferred in a semi-
dry chamber to a polyvinylidene diﬂuoride (PVDF) membrane.
Membranes were then incubated in blocking buffer (PBS-0.1%
Tween 20, 5% non-fat dry milk powder) followed by incuba-
tion for 60min with the monoclonal antibody (mab) P4 (R-
Biopharm), mab SAF-70 (SPIbio), or polyclonal antibody (pab)
Ra 10 (Groschup et al., 1994, 1997). In contrast to mab P4, which
detects ovine PrPC/res, pab Ra10 detects only murine PrPC/Sc.
Membranes were washed three times for 10min with PBS con-
taining 0.1% Tween 20 and then incubated with a secondary anti-
body bound to alkaline phosphatase (Goat-anti-mouse-alkaline
phosphatase or goat anti-rabbit-peroxidase). After washing, the
chemiluminescence substrate CDP-Star (Tropix) was applied and
membranes were incubated for 5min before the light signals were
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recorded on a Versadoc Imaging System (Biorad). Visualization
was carried out with the Biorad VersaDoc™quantiﬁcation soft-
ware Quantity One. The percentage of converted substrate was
calculated as: signal volume of PrPres digested with PK/signal vol-
ume of PrPC without PK∗10. Conversion rates were calculated for
each time point as a mean value from four independent reactions.
For stripping, membranes were incubated twice for 15min with a
buffer containing 0.2M glycine (pH 2.0) and 1% SDS.
PRPRES DETECTION FROM CELL CULTURE
Two scrapie-infected mouse cell lines were used: ScN2A-
cells [RML infected neuroblastoma-(N2A)-cells] and SMB-cells
(“scrapie-mouse-brain,” infected with strain 22F, a gift of TSE
Resource Centre at the Institute for Animal Health, UK). ScN2A-
cells were cultured in Opti-MEM, 10% fetal calf serum (FCS), and
5% CO2 at 37˚C. SMB-cells were cultured in MEM+ [MEM199,
10% newborn calf serum (NCS), 5% FCS] and 5% CO2 at
35˚C.
The cell-based assay was carried out according to Leidel et al.
(2011) with two scrapie-infected mouse cell lines: ScN2A-cells and
SMB-cells. These cells were adapted for dot blot procedure in
96-well plate format to identify potential inhibitors of PrPSc for-
mation. Compounds were resolved in DMSO and added to cells in
eight replicates in concentrations of 10, 100, and 1000μM (ﬁnal
concentration). After 3 days of incubation in a CO2-incubator,
the supernatants were removed and cells lysed in 100μl lysis
buffer (50mM Tris/HCl, 150mM NaCl, 0.5% Na-deoxycholate,
0.5% TX-100, pH 8.0). Lysates were or electrophoresed and
immunoblotted as described in the previous section or dot blot-
ted on PVDF membranes using a 96-well dot blot apparatus
(Transblotter, Roth). Dot blotting membranes were dried for 1 h
at 37˚C and ﬁxed sample incubated with DNAse (100μg/ml)
for 1 h at 37˚C. After rinsing the membranes twice with dis-
tilled water, the membrane was incubated with PK (25μg/ml)
for 90min at 37˚C. The digestion was terminated using PMSF
(2mM) and membranes were rinsed in 3M guanidium thio-
cyanate for 10min followed by washing them ﬁve times in distilled
water.
The incubation of the membrane with blocking buffer (PBS-
0.1% Tween 20, 5% non-fat dry milk powder) was followed by
an incubation for 60min with polyclonal antibody (pab) Ra 10.
Membranes were washed three times for 10min with PBS contain-
ing 0.1% Tween 20 and then incubated with a secondary antibody
bound to peroxidase (Goat anti-rabbit-PO).Afterward, the chemi-
luminescence substrate ECL (Roche) was applied and incubated
on the membrane for 1min before the light signals on the mem-
brane were detected directly in a camera. The intensity of the
PrPSc signal of each well was quantiﬁed by using the Versadoc
imaging system.Thehalf maximal (50%) inhibitory concentration
(IC50) of each compound was calculated from eight independent
reactions.
STATISTICAL ANALYSIS
Survival times were analyzed by Kaplan–Meier Survival analysis
using the log-rank test to compare the curves. The Statistical analy-
sis was done using SigmaBlot statistical software (San Jose, CA,
USA). Survival times are expressed as mean± SD.
RESULTS
The effect of S. lateriﬂora tea on the PrPres formation was ﬁrst
analyzed in vitro using two different scrapie-infected cell lines
(SMB and ScN2A-cells), which permanently accumulate PrPres.
When tea concentrate was added to the culture medium, a dose
dependent reduction of PrPres accumulation was observed in SMB
as well as ScN2A-cells (Figure 1). Cells were cultivated in T25
ﬂasks and incubated with increasing amounts of S. lateriﬂora
tea for 3 days. After this time, cells were harvested and the level
of PK-resistant PrPres was assessed by Western blotting. A dilu-
tion of 1:500 induced a reduction of PrPres to 58% for ScN2A
(Figure 1A, lane 2) and to 64% for SMB (Figure 1B, lane 2) cells
compared to the control (Figures 1A,B, lane 1). Dilutions of 1:50
resulted in a reduction to 33% for ScN2A-cells (Figure 1A, lane
3) and 57% for SMB-cells (Figure 1B, lane 3). About 1:20 dilu-
tions displayed reduction to 28% for ScN2A (Figure 1A, lane 4)
and 47% for SMB-cells (Figure 1B, lane 4) and reached values of
28.7% for ScN2A-cells (Figure 1A, lane 5) and 42.3% for SMB-
cells (Figure 1B, lane 5). Relative inhibition by tea is depicted in
Figure 1C.
To test the direct effects of tea on the conversion of PrPC to
PrPres, a cell-free conversion assay was used in which a puriﬁed
murine PrPSc template induced the conversion of recombinant
cellular PrPC into a PK-resistant PrPres fragment (Eiden et al.,
2006; Kupfer et al., 2007). Newly converted PrPres-fragments were
detected by mab P4 (Figure 2A, lanes 1–2), while PrPSc aggre-
gates were visualized by the polyclonal antibody Ra10 (Figure 2B,
lanes 1–2). Dried tea extract (3, 0.3, and 0.03mg respectively)
was added to the conversion assay, inhibited PrPres formation
and led to clearance of PrPres-fragments (Figure 2A, lanes 3–6).
Even 0.03mg caused a reduced PrPres formation compared to the
control (Figure 2A, lanes 7–8) by 23%.
Similar results were seen in the case of dissolution of PrPSc
aggregates after PK digestion (Figure 2B). In contrast to the con-
trol (Figure 2B, lanes 1–2), PrPSc aggregates were completely
digested if co-incubated with 3.0mg dried tea extract (Figure 2B,
lanes 3–4), as well as with 0.3mg (Figure 2B, lanes 5–6). About
0.03mg dried tea extract induced a partial disaggregation of
PrPSc aggregates (Figure 2B, lanes 7–8) by 40% compared to the
control.
To further characterize the underlying inhibitory mechanisms,
two main polyphenolic compounds of this herbal extract, the
ﬂavonoids Baicalin (baicalein 7-O-glucuronide) and its aglycone
baicalein (5,6,7-trihydroxyﬂavone), were studied with regard to
their inhibitory properties. Both components have been isolated
from this herb previously (Awad et al., 2003) und were also iden-
tiﬁed in this study as ingredients in the tea by LCMS–IT–TOF
hybrid mass spectrometry (data not shown). In addition, a struc-
tural analog to baicalein, the ﬂavonoid epicatechin and quercetin
were analyzed.
The potentially inhibitory effects on the PrPres accumulation
and conversion were assayed by a cell-based dot blot assay system
(Geissen et al., 2011) and the cell-free conversion assay. Struc-
tures, assay results, and half maximal (50%) inhibitory concen-
trations (IC50) of both compounds are summarized in Table 1.
The cell-based dot blot assay was carried out with two different
scrapie-infected SMB and ScN2A-cells again. Cells were seeded
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FIGURE 1 |Western blot analysis of inhibition of PrPres formation in
scrapie-infected cells by tea concentrate of S. lateriﬂora. (A)Tea
concentrate of S. lateriﬂora inhibits PrPres formation in ScN2A-cells.
Lane 1 shows PK-resistant fragments of the untreated control, lanes
2–5 a sample incubated with increasing concentrations of tea
concentrate of S. lateriﬂora: 1:500 (lane 2), 1:50 (lane 3), 1:20 (lane 4),
and 1:10 (lane 5). (B) Inhibition of PrPres formation in SMB-cells by tea
concentrate of S. lateriﬂora. PK-resistant fragments were detected in
untreated control (lane 1), after incubation with tea in a 1:500 dilution
(lane 2), 1:50 (lane 3), 1:20 and 1:10 (lane 5). Detection was carried out
with pab Ra10 and analyzed by standard chemiluminescence method.
(C) Relative inhibition (%) of PrPres formation by tea concentrate for
SMB (red line) and ScN2A (blue line) cells. +, incubation with
proteinase K (PK); u.d., undiluted.
in 96 wells and incubated with decreasing concentrations of the
corresponding ﬂavonoids (1mM, 100 and 10 μM). IC50 values of
Baicalein ranged from 138μM (SMB-cells) to 63.7 μM (ScN2A-
cells). Baicalin showed signiﬁcantly lower inhibitory effects com-
pared to baicalein in SMB-cells (IC50: >1000μM) as well as in
ScN2A-cells (IC50: 239.8μM). Two additional ﬂavonoids with
similar structure, epicatechin, and quercetin, showed also strong
inhibitory effects in both cell-types: epicatechin IC50 values were
96.6μM (ScN2A-cells) and 106.8μM (SMB-cells) and quercetin
IC50 valueswere 36.8μM(ScN2A-cells) and 274.3μM(SMB-cells;
Table 1). Baicalein displayed a strong dose dependent inhibitory
effects to PrPres formation (IC50: 18.48μM) and dissolution of
PrPSc aggregates (IC50: 41.56μM) in the cell-free conversion assay,
in contrast to baicalin which yielded IC50 values of >1000μM for
PrPres inhibition and 440μM for PrPSc dissolution. Epicatechin
and quercetin, although highly similar in structural to baicalein,
showed no inhibitory effects in cell-free conversion with regards
to PrPres formation and PrPSc disintegration.
In summary, these data demonstrate that tea of S. lateriﬂora
contains two active compounds, baicalein and baicalin, which are
speciﬁc inhibitors of PrPC conversion and PrPres ampliﬁcation
in vitro as well as enhance the degradation of PrPSc ﬁbrils.
In another set of experiments in vivo effects of S. lateriﬂora
tea were assessed. Wild-type mice were infected either by intrac-
erebrally (i.c.) or intraperitoneally (i.p.) inoculation with mouse
scrapie strain RML and the drinking water was replaced by freshly
brewed tea starting 2weeks prior to their inoculation and for
the whole lifetime of the mice. Survival times are depicted in
Figure 3. Six Bl6/C57 mice were used for the treatment and
compared to six intracerebrally inoculated mice which received
normal drinking water. The mean life spans of the control group
(Figure 5A, bold line) was 147± 3.1 dpi (Figure 3B) whereas the
tea treated mice (Figure 5A dashed line) survived signiﬁcantly
longer (184± 26.7 dpi; Figure 3B). Three of the treated mice sur-
vived up to 60 days compared to the control mice. In the case of
i.p. inoculation of RML strain, a mean prolongation of 15 days was
achieved (Figures 3C,D). The mean incubation time of the con-
trol group (Figure 3C, bold line) was 191± 8.6 dpi (Figure 3D)
whereas the tea treated mice (Figure 3C, dashed line) survived
signiﬁcantly longer (206± 8.6 dpi; Figure 3D).
Brains of the i.c. infected mice were subjected to compara-
tive biochemical and immunohistochemical investigations. PrP
immunoblot analysis revealed no differences of PrPSc banding pat-
terns and total amounts of PrPSc in both groups. The PrPSc content
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in all brains was analyzed after PK digestion and selective precip-
itation of PrPSc from corresponding mouse brain homogenates
with sodium phosphotungstic acid (Figure 4). No differences
FIGURE 2 |Western blot analysis of inhibition of PrPres formation and
disaggregation of pre-existing PrPSc fibrils in a cell-free conversion
assay. (A)Tea of S. lateriﬂora inhibits formation of PrPres. Lanes 1–2 show
PK-resistant PrPres-fragments in samples without tea, lanes 3–4 samples
after co-incubation with 3.0mg dried tea extract, lanes 5–6 with 0.3mg
dried tea extract, and lanes 7–8 co-incubation with 0.03mg dried tea
extract. Detection was carried out with mab P4. (B)Tea of S. lateriﬂora
disaggregates pre-existing ﬁbrils after digestion with PK. The membrane
from (A) was stripped and incubated another time with pab Ra10. Lanes
1–2 show PK-resistant PrPres-fragments in samples without tea, lanes 3–4
samples after co-incubation with 3.0mg dried tea extract, lanes 5–6 with
0.3mg dried tea extract, and lanes 7–8 co-incubation with 0.03mg dried tea
extract. Western blot was analyzed by standard chemiluminescence
method. +: incubation with proteinase K (PK).
in PrPSc banding patterns or PK resistances was detected in
mice which eventually developed scrapie in the tea treated and
control group (Figure 4, lanes 2–13). The brain lesion pro-
ﬁles and PrPSc deposition patterns in the different mouse brain
regions were similar for the treated and the untreated mice
(Figures 5A–D).
DISCUSSION
The here presented study demonstrates that solubilized ingredi-
ents of S. lateriﬂora not only inhibit the scrapie ﬁbril formation but
also destabilize pre-formed PrPSc ﬁbrils in a concentration depen-
dent manner. Main constituents of the herb were the polyphenolic
ﬂavonoids baicalin and baicalein, which were found at high con-
centrations in corresponding extracts. Both components in puri-
ﬁed form showed dose dependent inhibitory properties and thus
were the active constituents responsible for the herbs effects on
scrapie ﬁbril regulation.
The strongest effects displayed baicalein, the main metabolite
of baicalin,which inhibited PrPres accumulation in both cell-based
and cell-free assays and promoted the destabilization of PrPSc
ﬁbrils at low concentrations. A possible molecular mechanism
is based on direct binding to the PrPC and the formation of a
stable PrP–baicalein/baicalin complex, which blocks PrP conver-
sion and/or accumulation. In the same way the destabilization
of pre-existing ﬁbrils would be caused by a speciﬁc intercalation
of baicalein/baicalin into β-sheet structures of the PrPSc aggre-
gates which may lead to a forced PrPSc degradation by lysosomal
proteases. Similar effects by Baicalein have been described for the
inhibition of α-synuclein (Zhu et al., 2004) and amyloid-β peptide
(Aβ) ﬁbrillization (Lu et al., 2011).
Table 1 | Chemical structures of flavonoids and in vitro analyses.
Compound Dot blot IC50 (μM) Cell-free conversion assay IC50 (μM)
ScN2A SMB ScN2A SMB Prpres PrpSc Prpres PrpSc
63.7 139 18.48 41.56
239.8 >1000 >1000 440
96.9 106.8 n.e. n.e.
36.8 274.3 n.e. n.e.
IC50, Half maximal (50%) inhibitory concentration; n.e., not effective.
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FIGURE 3 |Tea of S. lateriﬂora prolongs incubation time in
scrapie-infected mice after oral treatment. (A) Oral treatment of
intracerebrally infected mice: Kaplan–Meier survival analysis of
intracerebrally scrapie (RML) infected C57/Bl6 mice after oral treatment
with tea of S. lateriﬂora.Treatment groups consisted of untreated
controls (), and tea treated mice (). (B) Mean survival times in primary
efﬁciency test±SD. Comparison of tea versus untreated controls was
carried out by log-rank test, p< 0.01(∗∗). (C) Oral treatment of
intraperitoneally infected mice: Kaplan–Meier survival analysis of
intraperitoneally scrapie (RML) infected C57/Bl6 mice after oral
treatment tea of S. lateriﬂora. Treatment groups consisted of untreated
controls (), and tea treated mice (). (D) Mean survival times in
primary efﬁciency test±SD. Comparison of tea versus untreated
controls, was carried out by log-rank test, p< 0.05(∗).
FIGURE 4 |Western blot analysis of sodium phosphotungstic acid
precipitation of PrPSc from brain homogenate of RML infected mice.
Proteinase K digested and sodium phosphotungstic acid precipitated PrPSc
was detected by mab SAF-70. Lane 1 shows an uninfected control, lanes 2–7
PrPSc from RML infected mouse brains and lanes 8–13 PrPSc from RML
infected mouse brains that were treated with tea from S. lateriﬂora. Western
blot was carried out with pab Ra10 and analyzed by chemiluminescence
method.
In our present study oral administration of S. lateriﬂora tea
signiﬁcantly prolonged incubation of mice either infected intrac-
erebral or intraperitoneal. These effects can be explained by direct
interference of baicalein to evolving PrP aggregates in the CNS.
Baicalein is able to cross the blood brain barrier and ultimately
reach the CNS (Tsai et al., 2002). Baicalin, on the other hand, may
act as pro-drug: After oral uptake, the sugar residue is cleaved by
enzymes in the intestinal tract to generate baicalein. The more
lipophilic baicalein is better absorbed in the gastrointestinal tract
and can then enter the brain via the blood system (Tarragó et al.,
2008).
Within the CNS, the inhibition and dissolution of prion aggre-
gates by Baicalein could protect neuronal cells from membrane
disruption and subsequent neuronal cell death. Additional anti-
oxidant properties of baicalein on reactive oxygen species (ROS),
which evolve during protein aggregation, may reinforce this
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FIGURE 5 | PrPSc accumulation in the brains of mice challenged with
RML. Immunohistochemistry: moderate diffuse PrPSc accumulation in the
cerebral cortex and multifocally in the corpus callosum of both (A) untreated
and (B) with tea treated mice. Detection was carried out with mab SAF 84.
Bar 200μm. H&E staining: mild vacuolation in the cerebral cortex of both
(C) untreated and (D) with tea treated mice, H&E staining, Bar 200μm.
neuroprotective effect (Li et al., 2010). Baicalein is able tominimize
ROSbydirectly quenching free radicals or indirectly inducing anti-
oxidant enzymes like superoxide dismutase and catalase (Shieh
et al., 2000; Kang et al., 2011).
Direct effects on the prion conversion were also seen in
other plant derived polyphenols like curcumin which is a strong
inhibitor of prion conversion replication in vitro (Caughey et al.,
2003). It is in vivo efﬁcacy, however, remains controversial: the
oral administration of curcumin had no signiﬁcant effect on
the onset of scrapie in hamsters (Caughey et al., 2003), whereas
scrapie-infected mice signiﬁcantly survived longer after oral treat-
ment (Riemer et al., 2008). Effects of other polyphenols (e.g.,
tannic acid, katacine, and 2′-2′′-bis epigallocatechin gallate) that
interfere with PrP conversion in vitro were also studied in vivo
(Kocisko et al., 2003). However, neither these substances nor mix-
tures of natural compounds including polyphenolic tea extract
and pine bark extracts displayed any effects on incubation periods
in scrapie-infected animals (Kocisko et al., 2004).
Up to now only few compounds have been reported that delay
onset on prion diseases after oral treatment. This includes pravas-
tatin (Vetrugno et al., 2009), which is involved in cholesterol
biosynthesis and inﬂuences membrane structure and function,
fucoidan (Doh-Ura et al., 2007), as well as amyloid dye derivatives
(Kawasaki et al., 2007). However, possible drug associated side-
effects have to be further evaluated. Recently, diphenyl-pyrazoles
(Leidel et al., 2011) were identiﬁed as a new class of anti-prion
compounds, which prolong incubation time of scrapie-infected
mice even after oral application.
In conclusion, beneﬁcial effects of S. lateriﬂora tea can be
explained by the anti-aggregatory and potential anti-oxidative
effects of its natural constituents, baicalein and baicalin. Only
few studies were conducted with herbal extracts of S. lateriﬂora
for prevention and therapy of protein misfolding diseases to date.
Results shown here for prion diseases are promising also in the
context of other diseases in this group.
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